SLC51B
Basic information
Region (hg38): 15:65045387-65053397
Links
Phenotypes
GenCC
Source:
- bile acid malabsorption, primary, 2 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bile acid malabsorption, primary, 2 | AR | Gastrointestinal | The condition has been described as manifesting with early-onset diarrhea, and medical management (eg, fat soluble vitamin supplementation) has been described as beneficial | Gastrointestinal | 28898457 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC51B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 12 | ||||
missense | 35 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 6 | 1 | 7 | |||
non coding | 7 | |||||
Total | 0 | 1 | 40 | 18 | 1 |
Variants in SLC51B
This is a list of pathogenic ClinVar variants found in the SLC51B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-65049998-CA-C | SLC51B-related disorder | Likely benign (Dec 20, 2022) | ||
15-65050001-G-A | SLC51B-related disorder | Likely benign (Aug 08, 2023) | ||
15-65050012-A-T | Uncertain significance (Aug 03, 2023) | |||
15-65050017-G-A | Uncertain significance (Dec 04, 2022) | |||
15-65050017-G-C | Uncertain significance (Jul 03, 2022) | |||
15-65050024-C-T | Uncertain significance (Aug 07, 2022) | |||
15-65050040-C-T | Likely benign (Mar 12, 2023) | |||
15-65050041-G-C | Uncertain significance (Dec 19, 2022) | |||
15-65050042-G-A | not specified | Uncertain significance (Jul 27, 2023) | ||
15-65050047-G-T | Uncertain significance (Nov 22, 2022) | |||
15-65050050-G-A | Uncertain significance (May 01, 2023) | |||
15-65050055-C-T | Likely benign (Nov 28, 2022) | |||
15-65050057-AGGAGCTGCT-A | Uncertain significance (May 16, 2023) | |||
15-65050068-G-A | Uncertain significance (Oct 26, 2022) | |||
15-65050073-G-C | Uncertain significance (Feb 22, 2023) | |||
15-65050075-T-C | Uncertain significance (Oct 29, 2023) | |||
15-65050075-T-G | Uncertain significance (Jul 15, 2022) | |||
15-65050082-GT-G | Cholestasis;Diarrhea • Bile acid malabsorption, primary, 2 | Likely pathogenic (Jun 20, 2019) | ||
15-65050100-T-C | Uncertain significance (Jul 21, 2023) | |||
15-65050113-G-C | Likely benign (Feb 01, 2023) | |||
15-65050119-G-A | Likely benign (Nov 17, 2022) | |||
15-65051499-G-C | Likely benign (Oct 20, 2023) | |||
15-65051510-C-G | Uncertain significance (Oct 13, 2023) | |||
15-65051512-C-T | Uncertain significance (Dec 12, 2023) | |||
15-65051522-C-G | Likely benign (Aug 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC51B | protein_coding | protein_coding | ENST00000334287 | 3 | 8027 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.245 | 0.652 | 125440 | 0 | 4 | 125444 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.457 | 54 | 64.3 | 0.840 | 0.00000295 | 830 |
Missense in Polyphen | 8 | 13.595 | 0.58846 | 181 | ||
Synonymous | 0.922 | 19 | 24.9 | 0.765 | 0.00000124 | 250 |
Loss of Function | 1.19 | 1 | 3.34 | 0.299 | 1.43e-7 | 36 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000870 | 0.0000870 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000881 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood. Efficiently transports the major species of bile acids. Modulates SLC51A glycosylation, membrane trafficking and stability activities. {ECO:0000269|PubMed:16317684}.;
- Pathway
- Bile secretion - Homo sapiens (human);Drug Induction of Bile Acid Pathway
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc51b
- Phenotype
Gene ontology
- Biological process
- bile acid and bile salt transport;regulation of protein stability;bile acid secretion;transmembrane transport;positive regulation of protein glycosylation;positive regulation of protein exit from endoplasmic reticulum;positive regulation of protein targeting to membrane
- Cellular component
- plasma membrane;integral component of membrane;basolateral plasma membrane;protein-containing complex
- Molecular function
- bile acid transmembrane transporter activity;protein heterodimerization activity